GGrantIndex
← Leaderboards

Manolis Kellis

Massachusetts Institute Of Technology

$46,984,324
Attributed
$89,218,988
Total exposure
26
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $12.1M · FY200725
$20M$15M$10M$5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$89,218,988 · 26

By mechanism

R01$48,113,275 · 13
U01$20,246,891 · 4
RF1$6,919,543 · 2
RC2$4,086,417 · 1
UH3$3,475,569 · 1
UG3$2,484,900 · 1

Most similar at Massachusetts Institute Of Technology

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposGenesMapsCell TypeEnhancersCellsData SetEpigenomicsPathway InteractionsNucleic Acid Regulatory SequencesGeneticVariantMolecularLinkAffectInsightPhenotypeBaseDissectionGene ExpressionResourcesSamplingGene Expression ProfileBrain

Grant awards (87)

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,610,459
U01 · FY2025 · DA · contact PI
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,752,943
R01 · FY2025 · NS
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease$1,068,252
R01 · FY2025 · AG · contact PI
Single-cell multi-region transcriptional and epigenomic dissection of VCID.$1,034,087
R01 · FY2025 · NS · contact PI
Single-cell multi-region dissection of AD-pathogen interactions for HSV-1 and CMV$727,847
R01 · FY2025 · AG · contact PI
Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD$700,630
R01 · FY2025 · AG · contact PI
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2025 · DA
Integration and Validation of Single-Cell Neuronal and Immune Molecular Responses in SUD and HIV$558,668
R01 · FY2025 · DA · contact PI
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,610,459
U01 · FY2024 · DA · contact PI
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,818,953
R01 · FY2024 · NS
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease$1,135,203
R01 · FY2024 · AG · contact PI
Single-cell multi-region dissection of AD-pathogen interactions for HSV-1 and CMV$752,834
R01 · FY2024 · AG · contact PI
Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD$725,002
R01 · FY2024 · AG · contact PI
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2024 · DA
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,433,874
U01 · FY2023 · DA · contact PI
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$2,054,384
R01 · FY2023 · NS
Construction of an Integrated Immune - Vascular Brain - Chip as a Platform for the Study, Drug Screening, and Treatments of Alzheimer's Disease$1,158,523
UH3 · FY2023 · NS
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease$1,080,026
R01 · FY2023 · AG · contact PI
Single-cell multi-region dissection of AD-pathogen interactions for HSV-1 and CMV$786,088
R01 · FY2023 · AG · contact PI
Investigating cell-type specific convergence of APOE and ABCA7 lipid dysregulation in Alzheimer’s disease$753,667
R56 · FY2023 · AG
Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD$733,242
R01 · FY2023 · AG · contact PI
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2023 · DA
Single-cell multi-region transcriptional and epigenomic dissection of VCID.$3,058,535
RF1 · FY2022 · NS · contact PI
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,447,914
U01 · FY2022 · DA · contact PI
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,662,271
R01 · FY2022 · NS
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease$1,294,415
R01 · FY2022 · AG · contact PI
Construction of an Integrated Immune-Vascular Brain - Chip as a Platform for the Study, Drug Screening, and Treatments of Alzheimer's Disease$1,158,523
UH3 · FY2022 · NS
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease$1,085,125
R01 · FY2022 · AG · contact PI
Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD$741,221
R01 · FY2022 · AG · contact PI
Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain$616,630
R01 · FY2022 · DA
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV$2,461,914
U01 · FY2021 · DA · contact PI
Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND$1,817,770
R01 · FY2021 · NS
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,552,886
R01 · FY2021 · AG · contact PI
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease$1,294,990
R01 · FY2021 · AG · contact PI
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease$1,158,523
UH3 · FY2021 · NS
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease$1,076,916
R01 · FY2021 · AG · contact PI
Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD$757,149
R01 · FY2021 · AG · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,578,214
R01 · FY2020 · AG · contact PI
Single-cell transcriptional and epigenomic dissection of Alzheimer's Disease and Related Dementias$1,345,399
U01 · FY2020 · NS · contact PI
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease$1,295,549
R01 · FY2020 · AG · contact PI
Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD$753,520
R56 · FY2020 · AG · contact PI
Network-based prediction and validation of causal schizophrenia genes and variants$398,193
R01 · FY2020 · MH · contact PI
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease$225,900
UG3 · FY2020 · NS
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease$2,259,000
UG3 · FY2019 · NS
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,610,182
R01 · FY2019 · AG · contact PI
Single-cell transcriptional and epigenomic dissection of Alzheimer's Disease and Related Dementias$1,345,399
U01 · FY2019 · NS · contact PI
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease$1,296,090
R01 · FY2019 · AG · contact PI
Single Cell Transcriptional and Epigenomic Dissection of Schizophrenia and Bipoloar Disease$624,981
U01 · FY2019 · MH · contact PI
Network-based prediction and validation of causal schizophrenia genes and variants$398,936
R01 · FY2019 · MH · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,642,247
R01 · FY2018 · AG · contact PI
Single-cell transcriptional and epigenomic dissection of Alzheimer's Disease and Related Dementias$1,348,579
U01 · FY2018 · NS · contact PI
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease$1,308,813
R01 · FY2018 · AG · contact PI
Network-based prediction and validation of causal schizophrenia genes and variants$427,188
R01 · FY2018 · MH · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,527,396
R01 · FY2017 · AG · contact PI
Interpreting non-coding variants using epigenomics, regulatory models, & validation experiments$546,251
R01 · FY2017 · HG · contact PI
Network-based prediction and validation of causal schizophrenia genes and variants$475,347
R01 · FY2017 · MH · contact PI
Comparative analysis and regulatory architecture of epigenomics datasets$284,959
R01 · FY2017 · GM · contact PI
Interpreting non-coding variants using epigenomics, regulatory models, & validati$162,708
R01 · FY2017 · HG · contact PI
Cell type specific epigenetic analysis to understand complex mechanisms underlying Alzheimer's disease phenotypes$3,861,008
RF1 · FY2016 · AG
Interpreting non-coding variants using epigenomics, regulatory models, & validati$812,809
R01 · FY2016 · HG · contact PI
Network-based prediction and validation of causal schizophrenia genes and variants$424,175
R01 · FY2016 · MH · contact PI
Comparative analysis and regulatory architecture of epigenomics datasets$284,106
R01 · FY2016 · GM · contact PI
Epigenomic variation atlas across human tissues and individuals in GTEx$100,000
U01 · FY2016 · HG · contact PI
Epigenomic variation atlas across human tissues and individuals in GTEx$941,793
U01 · FY2015 · HG · contact PI
Interpreting non-coding variants using epigenomics, regulatory models, & validati$811,770
R01 · FY2015 · HG · contact PI
Epigenomic variation atlas across human tissues and individuals in GTEx$450,000
U01 · FY2015 · HG · contact PI
Comparative analysis and regulatory architecture of epigenomics datasets$283,300
R01 · FY2015 · GM · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$55,688
R01 · FY2015 · HG · contact PI
Epigenomic variation atlas across human tissues and individuals in GTEx$1,291,947
U01 · FY2014 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$670,000
R01 · FY2014 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$406,271
R01 · FY2014 · HG · contact PI
Epigenomic variation atlas across human tissues and individuals in GTEx$234,173
U01 · FY2014 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$395,908
R01 · FY2013 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$414,563
R01 · FY2012 · HG · contact PI
A Data Analysis Center for integration of fly and worm modENCODE datasets$1,296,550
RC2 · FY2011 · HG · contact PI
Integrative analysis of genomic and epigenomic datasets in multiple cell types$449,390
RC1 · FY2011 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$306,571
R01 · FY2011 · HG · contact PI
A Data Analysis Center for integration of fly and worm modENCODE datasets$1,316,360
RC2 · FY2010 · HG · contact PI
Genome-wide chromatin modification targeting by endogenous small RNAs$996,415
RC1 · FY2010 · CA
Integrative analysis of genomic and epigenomic datasets in multiple cell types$468,161
RC1 · FY2010 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$372,834
R01 · FY2010 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$310,423
R01 · FY2010 · HG · contact PI
A Data Analysis Center for integration of fly and worm modENCODE datasets$1,473,507
RC2 · FY2009 · HG · contact PI
Integrative analysis of genomic and epigenomic datasets in multiple cell types$471,240
RC1 · FY2009 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$311,149
R01 · FY2009 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$310,352
R01 · FY2008 · HG · contact PI
Regulatory Morif Discovery in the Human Genome Using Comparative Genomics$313,861
R01 · FY2007 · HG · contact PI